Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Shares Outstanding (Diluted Average): 2021-2024

Historic Shares Outstanding (Diluted Average) for Krystal Biotech (KRYS) over the last 4 years, with Dec 2024 value amounting to $29.7 million.

  • Krystal Biotech's Shares Outstanding (Diluted Average) fell 0.23% to $29.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.8 million, marking a year-over-year decrease of 0.23%. This contributed to the annual value of $29.7 million for FY2024, which is 7.16% up from last year.
  • According to the latest figures from FY2024, Krystal Biotech's Shares Outstanding (Diluted Average) is $29.7 million, which was up 7.16% from $27.8 million recorded in FY2023.
  • In the past 5 years, Krystal Biotech's Shares Outstanding (Diluted Average) registered a high of $29.7 million during FY2024, and its lowest value of $22.2 million during FY2021.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $27.7 million, with a median of $27.8 million in 2023.
  • Data for Krystal Biotech's Shares Outstanding (Diluted Average) shows a peak YoY climbed of 14.85% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Krystal Biotech's Shares Outstanding (Diluted Average) stood at $22.2 million in 2021, then climbed by 14.85% to $25.5 million in 2022, then grew by 8.87% to $27.8 million in 2023, then grew by 7.16% to $29.7 million in 2024.